In mice with MASLD induced by methionine-choline deficiency and in HpeG2 cells treated with OA, naringenin reduced lipid accumulation through inhibition of the inflammatory cytokine-mediated signaling pathway NLRP3/NFkB [41]. Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.